These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21597951)

  • 1. Guidance on using tocilizumab for juvenile idiopathic arthritis.
    Yokota S; Imagawa T; Takei S; Murata T; Tomiita M; Itoh Y; Fujikawa S; Mori M
    Mod Rheumatol; 2011 Dec; 21(6):563-71. PubMed ID: 21597951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab for treating juvenile idiopathic arthritis.
    Turnier JL; Brunner HI
    Expert Opin Biol Ther; 2016; 16(4):559-66. PubMed ID: 26848760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.
    Machado SH; Xavier RM
    Expert Opin Drug Saf; 2017 Apr; 16(4):493-500. PubMed ID: 28277841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
    Tappeiner C; Heinz C; Ganser G; Heiligenhaus A
    J Rheumatol; 2012 Jun; 39(6):1294-5. PubMed ID: 22661419
    [No Abstract]   [Full Text] [Related]  

  • 6. Serious adverse events in children with juvenile idiopathic arthritis and other rheumatic diseases on tocilizumab - a real-world experience.
    Aeschlimann FA; Dumaine C; Wörner A; Mouy R; Wouters C; Melki I; Uettwiller F; Job-Deslandre C; Quartier P; Bader-Meunier B
    Semin Arthritis Rheum; 2020 Aug; 50(4):744-748. PubMed ID: 32526594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan.
    Yokota S; Imagawa T; Murata T; Tomiita M; Itoh Y; Fujikawa S; Takei S; Mori M
    Mod Rheumatol; 2012 Aug; 22(4):491-7. PubMed ID: 22258637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
    Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    Ann Rheum Dis; 2013 Apr; 72(4):627-8. PubMed ID: 23204515
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab in pediatric rheumatology: the clinical experience.
    Gurion R; Singer NG
    Curr Rheumatol Rep; 2013 Jul; 15(7):338. PubMed ID: 23715975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologicals in Juvenile Idiopathic Arthritis.
    Saini I; Dawman L; Gupta N; Kabra SK
    Indian Pediatr; 2016 Mar; 53(3):260-1. PubMed ID: 27029697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab for juvenile idiopathic arthritis: a single-center case series.
    Yazılıtaş F; Özdel S; Şimşek D; Aydoğ Ö; Çakıcı EK; Can GG; Güngör T; Bülbül M
    Sao Paulo Med J; 2019; 137(6):517-522. PubMed ID: 32159638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
    Cabrera N; Lega JC; Kassai B; Wouters C; Kondi A; Cannizzaro E; Woerner A; Chausset A; Roethlisberger S; Jeanneret C; Aeschlimann F; Malik S; Duquesne A; Kaiser D; Higel L; Maes A; Berthet G; Hentgen V; Kone-Paut I; Belot A; Hofer M
    Joint Bone Spine; 2019 May; 86(3):343-350. PubMed ID: 30201476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
    Miyamae T; Yokoya S; Yamanaka H; Yokota S
    Mod Rheumatol; 2014 Jul; 24(4):567-71. PubMed ID: 24252004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
    Quesada-Masachs E; Caballero CM
    J Rheumatol; 2017 Feb; 44(2):260-261. PubMed ID: 28148759
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis.
    Shimizu M; Hamaguchi Y; Ishikawa S; Ueno K; Yachie A
    Mod Rheumatol; 2015; 25(6):972-3. PubMed ID: 25496406
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
    Inaba Y; Ozawa R; Aoki C; Imagawa T; Mori M; Hara R; Miyamae T; Saito T; Yokota S
    Mod Rheumatol; 2013 Jul; 23(4):667-73. PubMed ID: 22791270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
    Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
    Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
    Woodrick RS; Ruderman EM
    Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.
    Kawada J; Kitagawa Y; Iwata N; Ito Y
    Mod Rheumatol; 2013 Sep; 23(5):972-6. PubMed ID: 23070362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
    Aoki C; Inaba Y; Choe H; Kaneko U; Hara R; Miyamae T; Imagawa T; Mori M; Oba MS; Yokota S; Saito T
    J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.